Allergy Therapeutics Plc - Company Profile
Powered by 
All the data and insights you need on Allergy Therapeutics Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Allergy Therapeutics Plc Strategy Report
- Understand Allergy Therapeutics Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Allergy Therapeutics Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 16 Oct 2023 | SkyGem Acquisition Acquires Stake in Allergy Therapeutics for Approximately USD58.16 Million | Acquisition |
SkyGem Acquisition Ltd
|
Allergy Therapeutics Plc |
| 31 Mar 2022 | Allergy Therapeutics Enters Manufacturing Agreement with AGC Biologics for VLP Peanut vaccine | Contract Service Agreement |
Allergy Therapeutics Plc
|
AGC Biologics Inc
|
| 10 Nov 2020 | Bencard AG Enters Phase IV Clinical Trial Agreement with ClinCompetence Cologne GmbH for beta lactoglobulin, ImmunoBon (GDCT0501272) | Contract Service Agreement |
Bencard AG
|
ClinCompetence Cologne GmbH
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer